NINLARO® (ixazomib) Treatment Guide NINLARO is a prescription medicine used to treat multiple myeloma in combination with the medicines REVLIMID® (lenalidomide) and …

May 20, 2025 · Ninlaro is a cancer medicine used to treat multiple myeloma (bone marrow cancer), in combination chemotherapy with lenalidomide and dexamethasone.

Jul 14, 2024 · Ixazomib (Ninlaro®) is a proteasome inhibitor used with other medications for the treatment of multiple myeloma. Ixazomib works by inhibiting the 20S proteasome. A …

NINLARO is a prescription medicine used to treat multiple myeloma in combination with the medicines REVLIMID® (lenalidomide) and dexamethasone, in people who have received at …

May 23, 2024 · In 2015, the U.S. Food and Drug Administration approved NINLARO® (ixazomib) for the treatment of adult patients with myeloma who have received at least 1 prior therapy. …

Ninlaro (ixazomib) is a proteasome inhibitor used with lenalinomide and dexamethasone for adults with multiple myeloma who received prior therapy. See its full prescribing information.

Learn about the NINLARO® (ixazomib) treatment combination for multiple myeloma that has returned that may help you keep an active lifestyle. See Important Safety Information and …

INDICATION AND USAGE Indication: NINLARO is indicated in combination with lenalidomide and dexamethasone for the treatment of patients with multiple myeloma who have received at least …

Ninlaro is a prescription medicine used to treat multiple myeloma in combination with the medicines Revlimid (lenalidomide) and dexamethasone, in people who have received at least …

This Treatment Guide contains information about ixazomib, a treatment used in myeloma. This publication is part of our Treatment Guide series, a collection of booklets covering the different …